Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Lymphoma Treatments
Pharma
A new complaint emerges in BMS' contingent value rights lawsuit
New details have come out in Bristol Myers Squibb's lawsuit over a scuppered Contingent Value Rights (CVR) payout tied to its Celgene takeover.
Fraiser Kansteiner
Feb 23, 2022 1:10pm
BMS, Gilead lock horns in CAR-T for 2L lymphoma
Dec 11, 2021 8:30am
Epizyme follicular lymphoma campaign showcases interactive coach
Nov 18, 2021 10:47am
ADC taps commercial manufacturer for its new blood cancer med
May 25, 2021 10:52am
Gilead’s Kite taps Eisai vet to helm CAR-T commercial strategy
Jul 10, 2018 10:30am
Roche eyes new Gazyva data as Rituxan-beating boost
Dec 5, 2016 9:27am
